G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Income from Continuing Operations Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Income from Continuing Operations
kr17.3m
CAGR 3-Years
14%
CAGR 5-Years
30%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Income from Continuing Operations
kr192m
CAGR 3-Years
-28%
CAGR 5-Years
8%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Income from Continuing Operations
-kr1.7B
CAGR 3-Years
-226%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Income from Continuing Operations
kr250m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
18%
MedCap AB (publ)
STO:MCAP
Income from Continuing Operations
kr214.1m
CAGR 3-Years
48%
CAGR 5-Years
38%
CAGR 10-Years
24%
M
Magle Chemoswed Holding AB
STO:MAGLE
Income from Continuing Operations
kr12.2m
CAGR 3-Years
89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genovis AB's Income from Continuing Operations?
Income from Continuing Operations
17.3m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Income from Continuing Operations amounts to 17.3m SEK.

What is Genovis AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
30%

Over the last year, the Income from Continuing Operations growth was -70%. The average annual Income from Continuing Operations growth rates for Genovis AB have been 14% over the past three years , 30% over the past five years .

Back to Top